An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder

NCT02226458 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped This study was halted prior to enrolling.

Conditions

Interventions

Sponsor

Edison Pharmaceuticals Inc